Since we observed a major role of PTPRK in checking glioma aggressiveness (proliferation, diffusion and invasion), and as malignant gliomas are characterized by a remarkably high chemo-resistance, we analyzed whether PTPRK status modulates the chemosensitivity of malignant glioma cells. This evidence concerns the gene PTPRK and central nervous system cancer.